Anzeige
Mehr »
Dienstag, 01.07.2025 - Börsentäglich über 12.000 News
Nächster Kursturbo?: 226 % Plus seit Januar - wie weit kann diese Aktie noch steigen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 502816 | ISIN: GB0009223206 | Ticker-Symbol: NPW1
Tradegate
01.07.25 | 09:30
13,235 Euro
+0,76 % +0,100
1-Jahres-Chart
SMITH & NEPHEW PLC Chart 1 Jahr
5-Tage-Chart
SMITH & NEPHEW PLC 5-Tage-Chart
RealtimeGeldBriefZeit
13,05013,25011:00
13,04513,25011:02

Aktuelle News zur SMITH & NEPHEW Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SoSmith & Nephew UK Ltd: Global Sports Medicine leader Smith+Nephew to sponsor select players competing at Wimbledon, highlighting advanced solutions for joint repair375Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces it will once again support select players during high profile matches at The Championships, Wimbledon in 2025. The world's...
► Artikel lesen
SMITH & NEPHEW Aktie jetzt für 0€ handeln
MiSmith+Nephew launches Trigen Max tibia nailing system5
24.06.Smith+Nephew appoints chief corporate development & strategy officer3
24.06.Smith & Nephew UK Ltd: Smith+Nephew's new TRIGEN MAX Tibia Nailing System brings 'next-level nailing' to trauma surgeons repairing tibial fractures261The future of fracture fixation with novel side-specific nails featuring variable angle locking technology Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces...
► Artikel lesen
23.06.Smith & Nephew hires Mckinsey alum Ajay Dhankar to executive board3
23.06.Smith & Nephew appoints Ajay Dhankhar as chief corporate development & strategy officer5
23.06.Smith & Nephew UK Ltd: Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer277Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, announces the appointment of Ajay Dhankhar, PhD, as Chief Corporate Development & Strategy Officer, effective today. Ajay will...
► Artikel lesen
20.06.Smith+Nephew Stock May Gain From Strategic Deal With Standard Health3
18.06.Smith+Nephew to open first orthopedic ambulatory surgery center in the UK3
18.06.Smith & Nephew UK Ltd: Smith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UK475Smith+Nephewto support the development of the first-ever Orthopaedic Ambulatory Surgery Centre in the UK. Based in Poole, Dorset, the new centre will offer NHS and private patients access to leading...
► Artikel lesen
13.06.Smith+Nephew opens new medtech center in Barcelona4
13.06.Smith+Nephew ernennt David King zum Non-Executive Director7
13.06.Smith+Nephew appoints David King as non-executive director2
13.06.Smith & Nephew Plc - Directorate Change7
10.06.Smith+Nephew introduces new medial stabilized insert for Legion TKS4
09.06.Smith & Nephew UK Ltd: New medial stabilized insert for Smith+Nephew's LEGION Total Knee System designed to improve kinematics, stability and procedural versatility331Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the introduction of a new medial stabilized insert for its LEGION Total Knee System (TKS). Medial stabilized inserts...
► Artikel lesen
06.06.SMITH & NEPHEW PLC - 6-K, Report of foreign issuer4
06.06.Smith & Nephew Plc - Director/PDMR Shareholding2
02.06.Smith & Nephew Plc - Total Voting Rights4
30.05.SMITH & NEPHEW PLC - 6-K, Report of foreign issuer1
Weiter >>
115 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1